- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07579130
Comparative Assessment of Lipid Layer Thickness Measurements
May 6, 2026 updated by: Anna Tichenor, Indiana University
Comparative Assessment of Lipid Layer Thickness Measurements Across Three Devices and Their Correlation With Clinical Indicators in Dry Eye Disease
This study compares ocular lipid layer thickness (LLT) measurements obtained from three commonly used clinical diagnostic devices to evaluate their agreement and consistency.
It further examines which device's LLT measurements show the strongest correlation with established clinical indicators of dry eye disease severity.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anna Tichenor
- Phone Number: 8128550520
- Email: annatich@iu.edu
Study Locations
-
-
Indiana
-
Bloomington, Indiana, United States, 47405
- Recruiting
- Atwater Eye Care Center
-
Contact:
- Anna Tichenor
- Phone Number: 812-855-0520
- Email: annatich@iu.edu
-
Principal Investigator:
- Anna Tichenor, OD PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients presenting to the clinic with dry eye disease symptoms will be included in the study.
Description
Inclusion Criteria:
- Dry eye disease
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Dry Eye
Patients with dry eye disease will undergo measurement of lipid layer thickness on all 3 devices in random order.
|
Subjects will undergo lipid layer thickness measurement
Subjects will undergo lipid layer thickness measurement
Subjects will undergo lipid layer thickness measurement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lipid Layer Thickness
Time Frame: measurements taken at single visit, baseline
|
Average and minimum lipid layer thickness measurements will be compared across devices
|
measurements taken at single visit, baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation with dry eye clinical measurements
Time Frame: measurements taken at single visit, baseline
|
Correlations will be compared and analyzed with clinical dry eye measuremetns
|
measurements taken at single visit, baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2026
Primary Completion (Estimated)
December 20, 2028
Study Completion (Estimated)
December 20, 2028
Study Registration Dates
First Submitted
April 30, 2026
First Submitted That Met QC Criteria
May 6, 2026
First Posted (Actual)
May 11, 2026
Study Record Updates
Last Update Posted (Actual)
May 11, 2026
Last Update Submitted That Met QC Criteria
May 6, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 29789
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
Universiti Sains MalaysiaNot yet recruitingDry Eye Disease (DED) | Dry Eye Symptoms | Dry Eye Syndrome (DES)Malaysia
-
The University of New South WalesUniversity of MelbourneRecruitingDry Eye Disease (DED)Australia
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Dry Eye Syndromes | Dry Eyes Chronic
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
University of MiamiNot yet recruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
BioTissue Holdings, IncCompletedDry Eye | Dry Eye Disease (DED) | Dry Eye Disease With Severe KeratitisUnited States
-
Southern College of OptometryRecruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
Laboratoires TheaRecruitingDry Eye Disease (DED)Bulgaria
Clinical Trials on LipiView
-
Singapore National Eye CentreCompleted
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Singapore National Eye CentreCompleted
-
Fondation Ophtalmologique Adolphe de RothschildCompletedKeratoconjunctivitis | Meibomian Gland Dysfunction | Ocular RosaceaFrance